A study from the University of Washington Seattle studied the incidence of Graves’ disease before and after receiving the COVID-19 vaccine, determining no significant difference. Researchers also looked at levels of thyroid antibodies in the blood of patients with Graves’ hyperthyroidism before and after vaccination and found no significant difference.
Read More »An article published in Nature provides the most comprehensive compilation of research on long Covid to date, discussing what is currently known about its symptoms, prevalence, biomarkers, and disease mechanisms. Because long Covid does not have a single unifying mechanism, and has such broad multi-systemic symptoms, it likely has a broad range of causes and will likely be classified into separate illnesses in the future.
Read More »A recent study cited in Lupus Science and Medicine covered vaccine safety in patients with Systemic Lupus Erythematosus. 237 vaccinated SLE participants were included, and researchers found that rates of vaccine side effects reported by those with SLE were statistically similar to those in the general public; additionally, the majority of patients did not experience disease flare-ups in response to vaccination.
Read More »As part of its Researching COVID to Enhance Recovery (RECOVER) Initiative, NIH has opened enrollment for clinical trials at sites around the country that will test potential treatments for Long COVID. Treatments include drugs, biologics, medical devices, and other therapies. A protocol that will be launched n the coming months will study treatments related to symptoms of the autonomic nervous system and the first trials will focus on treatments for people who develop postural orthostatic tachycardia syndrome (POTS) following SARS-CoV-2 infection.
Read More »